参考文献 References
[1] Cordaro M, Siracusa R, Fusco R, et al. Involvements of Hyperhomocysteinemia in Neurological Disorders[J]. Metabolites. 2021,11(1):37.
[2] Tomioka Y, Kinoshita M, Umehara H, et al. Association between serum folate levels and schizophrenia based on sex[J]. Psychiatry Clin Neurosci,2020,74(9):466-471.
[3] 邹晓君, 彭光海, 易峰. 精神分裂症患者血清同型半胱氨酸水平与P300的相关[J].中国健康心理学杂志, 2014, 22(3):321-323.
[4] Pedroso RV, Fraga FJ, Pavarini SCI, et al. A Systematic Review of Altered P300 Event-Related Potential in Apolipoprotein E4 (APOE4) Carriers[J]. Clin EEG Neurosci, 2021, 52(3):193-200.
[5] Sharma A, Gerbarg P, Bottiglieri T, et al. S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research[J]. J Clin Psychiatry, 2017,78(6):e656-e667.
[6] Sakuma K, Matsunaga S, Nomura I, et al. Folic acid/methylfolate for the treatment of psychopathology in schizophrenia: a systematic review and meta-analysis[J]. Psychopharmacology (Berl), 2018, 235(8):2303-2314.
[7] Tomioka Y, Kinoshita M, Umehara H,et al. Association between serum folate levels and schizophrenia based on sex[J]. Psychiatry Clin Neurosci, 2020,74(9):466-471.
[8] 朱祖欣, 熊鹏, 贾敏, 等.首发精神分裂症患者的血清同型半胱氨酸水平及其与P300的关系[J]. 中国神经精神疾病杂志, 2010, 36(6) :355-358.
[9] 陈旭梅, 朱琪玥, 张伟, 等.首发精神分裂症患者血清叶酸、同型半胱氨酸水平及其与认知功能的关系[J]. 中华医学杂志, 2014, 94(13) :990-993.
[10] Petronijević ND, Radonjić NV, Ivković MD, et al. Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2008, 32(8): 1921-1926.
[11] Huang Y, Wu K, Li H, et al. Homocysteine level, body mass index and clinical correlates in Chinese Han patients with schizophrenia. Sci Rep. 2020, 30;10(1):16119.
[12] Kinoshita M, Numata S, Tajima A, et al. Plasma total homocysteine is associated with DNA methylation in patients with schizophrenia[J]. Epigenetics, 2013, 8(6):584-590.
[13] Chia SC, Henry J, Mok YM, et al. Fatty acid and vitamin interventions in adults with schizophrenia: a systematic review of the current evidence[J]. J Neural Transm (Vienna), 2015, 122(12):1721-1732.
[14] 廖世鹏, 苏邹, 杨玉红, 等. 叶酸辅助利培酮治疗对精神分裂症患者血清脑源性神经营养因子、同型半胱氨酸及炎性细胞因子的影响[J]. 广西医学, 2019, 1;41(1):43-47.
[15] 彭兴, 高志华, 马辛, 等. 精神分裂症语义加工异常及认知功能缺陷[J]. 中国健康心理学杂志, 2020, 28(8) :1121-1125.
[16] Kim M, Lee TH, Kim JH, et al. Decomposing P300 into correlates of genetic risk and current symptoms in schizophrenia: An inter-trial variability analysis[J]. Schizophr Res, 2018 ,192:232-239.
[17] de Wilde OM, Bour LJ, Dingemans PM, Koelman JH, Boerée T, Linszen DH. P300 deficits are present in young first-episode patients with schizophrenia and not in their healthy young siblings. Clin Neurophysiol[J]. 2008 , 119 (12): 2721-2726.
[18] 王长虹, 李晏, 刘旭, 等. 奎硫平、利培酮对首发精神分裂症患者认知功能及P300的影响[J]. 中国心理卫生杂志, 2005, 19(5):333-336.
[19] 陈汉波, 付飞. 利培酮及氯氮平对首发精神分裂症患者认知功能及P300的影响研究[J].中国继续医学教育, 2020,12(24):165-167.
[20] Hamilton HK, D'Souza DC, Ford JM, et al. Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia[J]. Schizophr Res, 2018 ,191:87-94.
[21] Zhou S, Huang Y, Feng Y, et al. Association between plasma homocysteine levels and cognitive deficits in Han Chinese patients with schizophrenia across age groups[J]. Sci Rep.,2021, 11(1):19716.